Cargando…

EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress

Therapeutic options for advanced stage cholangiocellular carcinoma (CCC) are very limited as of today and patients carry an exceptionally poor overall prognosis. In recent years, increasing evidence has been accumulated to suggest that malignant cells widely show increased intrinsic ROS levels and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisht, Savita, Nolting, Jens, Wenzel, Jörg, Brossart, Peter, Feldmann, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425401/
https://www.ncbi.nlm.nih.gov/pubmed/30949204
http://dx.doi.org/10.1155/2019/8701824
_version_ 1783404836638687232
author Bisht, Savita
Nolting, Jens
Wenzel, Jörg
Brossart, Peter
Feldmann, Georg
author_facet Bisht, Savita
Nolting, Jens
Wenzel, Jörg
Brossart, Peter
Feldmann, Georg
author_sort Bisht, Savita
collection PubMed
description Therapeutic options for advanced stage cholangiocellular carcinoma (CCC) are very limited as of today and patients carry an exceptionally poor overall prognosis. In recent years, increasing evidence has been accumulated to suggest that malignant cells widely show increased intrinsic ROS levels and exhibit altered redox profiles as compared to normal counterparts, opening up potential avenues for therapeutic intervention. This study provides preclinical experimental evidence of therapeutic activity of the curcumin analog EF24 in cholangiocarcinoma models. In CCC cell lines, EF24 inhibited cell viability and induced apoptosis through excessive ROS generation. Moreover, administration of EF24 led to depletion of total intracellular GSH levels, induced mitochondrial depolarization, and abrogated STAT3 phosphorylation. Of interest, these effects were readily averted by treating the cells with exogenous antioxidants such as N-acetyl cysteine (NAC) or glutathione monoethyl ester (GEE). In vivo, EF24, solubilized using a cyclodextrin formulation, significantly suppressed the growth of tumor xenografts without exhibiting any toxic adverse effects. Immunohistochemical analysis of extracted tumor tissues demonstrated reduced nuclear staining for Ki-67 and downregulation of phospho-STAT3 as well as strong staining for oxidative stress biomarker 8-OHdG. Therefore, the data presented here suggest EF24 as potential therapeutic compound against CCC which might act at least to some extent through ROS-induced oxidative damage, subsequently inducing apoptosis. Further evaluation of this approach should be carried out in future follow-up studies.
format Online
Article
Text
id pubmed-6425401
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-64254012019-04-04 EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress Bisht, Savita Nolting, Jens Wenzel, Jörg Brossart, Peter Feldmann, Georg J Oncol Research Article Therapeutic options for advanced stage cholangiocellular carcinoma (CCC) are very limited as of today and patients carry an exceptionally poor overall prognosis. In recent years, increasing evidence has been accumulated to suggest that malignant cells widely show increased intrinsic ROS levels and exhibit altered redox profiles as compared to normal counterparts, opening up potential avenues for therapeutic intervention. This study provides preclinical experimental evidence of therapeutic activity of the curcumin analog EF24 in cholangiocarcinoma models. In CCC cell lines, EF24 inhibited cell viability and induced apoptosis through excessive ROS generation. Moreover, administration of EF24 led to depletion of total intracellular GSH levels, induced mitochondrial depolarization, and abrogated STAT3 phosphorylation. Of interest, these effects were readily averted by treating the cells with exogenous antioxidants such as N-acetyl cysteine (NAC) or glutathione monoethyl ester (GEE). In vivo, EF24, solubilized using a cyclodextrin formulation, significantly suppressed the growth of tumor xenografts without exhibiting any toxic adverse effects. Immunohistochemical analysis of extracted tumor tissues demonstrated reduced nuclear staining for Ki-67 and downregulation of phospho-STAT3 as well as strong staining for oxidative stress biomarker 8-OHdG. Therefore, the data presented here suggest EF24 as potential therapeutic compound against CCC which might act at least to some extent through ROS-induced oxidative damage, subsequently inducing apoptosis. Further evaluation of this approach should be carried out in future follow-up studies. Hindawi 2019-03-04 /pmc/articles/PMC6425401/ /pubmed/30949204 http://dx.doi.org/10.1155/2019/8701824 Text en Copyright © 2019 Savita Bisht et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bisht, Savita
Nolting, Jens
Wenzel, Jörg
Brossart, Peter
Feldmann, Georg
EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress
title EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress
title_full EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress
title_fullStr EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress
title_full_unstemmed EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress
title_short EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress
title_sort ef24 suppresses cholangiocellular carcinoma progression, inhibits stat3 phosphorylation, and induces apoptosis via ros-mediated oxidative stress
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425401/
https://www.ncbi.nlm.nih.gov/pubmed/30949204
http://dx.doi.org/10.1155/2019/8701824
work_keys_str_mv AT bishtsavita ef24suppressescholangiocellularcarcinomaprogressioninhibitsstat3phosphorylationandinducesapoptosisviarosmediatedoxidativestress
AT noltingjens ef24suppressescholangiocellularcarcinomaprogressioninhibitsstat3phosphorylationandinducesapoptosisviarosmediatedoxidativestress
AT wenzeljorg ef24suppressescholangiocellularcarcinomaprogressioninhibitsstat3phosphorylationandinducesapoptosisviarosmediatedoxidativestress
AT brossartpeter ef24suppressescholangiocellularcarcinomaprogressioninhibitsstat3phosphorylationandinducesapoptosisviarosmediatedoxidativestress
AT feldmanngeorg ef24suppressescholangiocellularcarcinomaprogressioninhibitsstat3phosphorylationandinducesapoptosisviarosmediatedoxidativestress